Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastroenterology
•
Gastrointestinal Functional & Motility Disorders
•
Primary Care
Are there data to support the use of herbal supplements, prebiotics, or probiotics in the management of SIBO?
Related Questions
Is there a particular prokinetic agent that you recommend if a patient has failed both PPI and TCA in the treatment of suspected functional dyspepsia?
In what scenario would you stack a patient on multiple laxatives (ex: Linzess + Prucalopride) if they have an incomplete response to single agent therapies?
How do you choose between resmetirom and semaglutide in the treatment of MASH?
Do you recommend the use of SGLT2 inhibitors to reduce the risk of liver cirrhosis in patients with Type 2 diabetes mellitus?
Do you recommend routinely monitoring pancreatic markers such as amylase and lipase while receiving GLP1 R agonist or dual agonist therapies to determine their risk of pancreatitis?
How do you adjust medications for patients with eosinophilic esophagitis who responded to budesonide or PPI, and when do you repeat EGD?
How do people approach non-HIV patients with hepatitis B, a negative Hepatitis B E antigen, normal LFTs and relatively low HBV DNA between 2000-20000?
How do you approach the treatment of microscopic colitis?
How often would you perform an upper endoscopy on an individual with chronic gastritis and previously eradicated H pylori with respect to risk of gastric malignancy?
Can rapid weight loss following GLP1 R agonist therapy lead to postprandial hypoglycemia and if so, what are the treatment options outside of dietary modifications?
